Why I ’m Considering Low-dose Naltrexone for My MS

Ever since my post of last week stating that I was ready to get back on a disease modifying therapy for my MS, I’ve been hearing from our Life With MS community about that decision.  Most are supportive. Some believe I am making a mistake.  The greatest number of specific suggestions are that I look into low-dose Naltrexone (LDN) as an option.
It’s been a number of years since we conversed on the topic of LDN.  I’ve continued to monitor the progress of research as results have become available and my opinion of LDN as a disease modifying therapy for MS has not changed.
I do not believe that evidence proves that it helps slow the progression of MS.
Why, therefore, am I contemplating the use of LDN if I don’t think it will slow my multiple sclerosis?  Because of the anecdotal evidence that it makes life just a little bit easier for people living with MS.  Not that the MS gets any better … rather that the up-regulation of endorphins has a positive quality-of-life effect for many living with this disease.
We all know that the living with the disease part of a life with MS can be difficult.  Even though clinical results of actual symptom levels don’t seem to be effected by LDN use, patient reports of overall well-being seem to improve.  In other words, LDN doesn’t seem to change the course of the disease, but it does seem to have a positive effect on the mental state of people coping with MS.
I liken it to a friend who had some flight anxiety issues and took ...

Source: Life with MS - October 28, 2016 Category: Neurology Authors: Trevis Gleason Tags: multiple sclerosis community life with MS Living with MS MS treatment multiple sclerosis clinical trials Source Type: blogs